Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUtil Regulatory News (UTL)

Share Price Information for Util (UTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.50
Bid: 101.00
Ask: 106.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.95%)
Open: 103.50
High: 103.50
Low: 103.50
Prev. Close: 103.50
UTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of monthly factsheet

7 Mar 2023 14:56

RNS Number : 1914S
UIL Limited
07 March 2023
 

7 March 2023

 

UIL LIMITED

(LEI Number: 213800CTZ7TEIE7YM468)

 

Publication of monthly factsheet

 

The latest monthly factsheet for UIL Limited ("UIL" or the "Company") will shortly be available through the Company's website at:

https://www.uil.limited/investor-relations/factsheet-archive

 

Monthly commentary

 

PERFORMANCE

UIL's NAV total return was down 12.9% in February, underperforming the FTSE All Share total return Index which was up by 1.5% over the month.

 

Unlike the positive "risk-on" market rally witnessed in January, fuelled by falling inflation data and expectations that key central banks are nearing the end of their aggressive interest rate rising cycle, February saw the majority of markets experience weakness and becoming "risk-off". This swing in markets was driven by stronger than expected economic data, such as indications of a continued tight labour market from the US, indicating that a recession may not be on the horizon and subsequently inflationary pressures could persist for longer, resulting in the reduction of interest rate cuts to come later and possibly at a slower pace than anticipated. The US Federal Reserve Bank's Chairman Jay Powell also indicated that further rate increases are likely, especially if strong macro data continues to persist. During February, the Federal Bank increased rates by 25bps to 4.75%, whilst both the Bank of England and the European Central Bank increased by 50bps raising interest rates to 4.0% and 2.5% respectively. The S&P Index was therefore down for the month by 2.6%. The Eurostoxx Index however performed better, up by 1.8%, along with other European Indices and continues to be one of the best performing equity markets year to date due to a more positive outlook.

 

Emerging markets were also weak. The Hang Seng Index declined in February by 9.4%, despite the expectation that the re-opening of China post Covid-19 might lead to a rapid consumption boom due to the high amount of savings built up during lock down. Continued geopolitical tension led to some profit taking. The Chinese A-share market weathered the geopolitical pressures better as the Shanghai Composite was essentially flat for February, up marginally by 0.7%. The Brazilian Bovespa declined by 7.5% in February, due to deterioration of investors' sentiment in the face of uncertain economic policy.

 

Sterling was mixed, strengthening 2.8% against the Australian Dollar and 0.7% against the Euro, but weakened 1.7% against the US Dollar, and 1.5% against the Hong Kong Dollar. Notably the US Dollar had its first positive month since September 2022, benefitting from the expectation of an extended US monetary policy tightening cycle. Commodities also saw weakness, with gold down by 5.3% and copper down by 3.0%. The Brent crude oil price weakened slightly, down by 0.7% in February.

 

PORTFOLIO

There was one change to the top ten constituents of the UIL portfolio in February. Allectus Quantum Holdings replaced Panoramic Resources due to share price weakness and a reduction in position. Allectus Quantum is an investment holding company investing in quantum technology.

 

Somers' valuation was down 11.1% in February, partly reflecting the weakness of Resimac's share price that was down by 17.2% for the month. Resimac's share price was down following its half year results, as management guided towards lower margins in the second half of 2023 and expected increased competition from major banks and higher funding rates. AssetCo's share price was also down 9.5% after reporting a loss for the full year 2022.

 

DEBT

Bank borrowings of £50.0m drawn in Sterling remained unchanged over the month. There were no foreign exchange hedges in place during the month.

 

ZDP SHARES

The share price of the 2028 ZDP shares increased by 5.4% to 98.00p whilst the 2024 ZDP shares remined flat for the period at 123.50p. The 2026 ZDP shares declined marginally by 0.4% to 114.00p. The yields to redemption on the ZDP shares at the end of February were 7.0% for the 2024 ZDP shares, 8.1% for the 2026 ZDP shares and 8.1% for the 2028 ZDP shares.

 

OTHER

UIL's ordinary share price decreased by 11.7% to 143.00p in February whilst the discount to NAV narrowed slightly to 38.1% from 38.9%.

 

A second quarterly interim dividend of 2.00p per ordinary share in respect of the year ending 30 June 2023 was declared, which will be paid on 31 March 2023 to shareholders on the register on 3 March 2023.

 

 

Name of contact and telephone number for enquiries:

 

Charles Jillings

ICM Investment Management Limited +44(0)1372 271486

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCSSIFLWEDSEID
Date   Source Headline
11th Apr 20239:55 amRNSDirector/PDMR Shareholding - Saville
6th Apr 202312:17 pmRNSNet Asset Value(s)
6th Apr 20237:00 amRNSDirector/PDMR Shareholding - Shillson
6th Apr 20237:00 amRNSDirector/PDMR Shareholding - Hill
6th Apr 20237:00 amRNSDirector/PDMR Shareholding - Bridges
5th Apr 202311:39 amRNSNet Asset Value(s)
4th Apr 202312:11 pmRNSNet Asset Value(s)
3rd Apr 20232:59 pmRNSDirector/PDMR Shareholding - Samuel
3rd Apr 20231:34 pmRNSNet Asset Value(s)
3rd Apr 202312:03 pmRNSHolding(s) in Company
31st Mar 202311:16 amRNSNet Asset Value(s)
30th Mar 20231:15 pmRNSNet Asset Value(s)
29th Mar 20234:37 pmRNSPortfolio update
29th Mar 202312:12 pmRNSNet Asset Value(s)
28th Mar 202312:11 pmRNSNet Asset Value(s)
27th Mar 20232:02 pmRNSHolding(s) in Company
27th Mar 202312:15 pmRNSNet Asset Value(s)
24th Mar 202311:06 amRNSNet Asset Value(s)
23rd Mar 202312:05 pmRNSNet Asset Value(s)
22nd Mar 202311:25 amRNSNet Asset Value(s)
21st Mar 202311:30 amRNSNet Asset Value(s)
20th Mar 202311:21 amRNSNet Asset Value(s)
17th Mar 202312:13 pmRNSNet Asset Value(s)
16th Mar 202312:16 pmRNSNet Asset Value(s)
15th Mar 202311:57 amRNSNet Asset Value(s)
14th Mar 202312:08 pmRNSNet Asset Value(s)
13th Mar 202311:45 amRNSNet Asset Value(s)
10th Mar 202311:54 amRNSNet Asset Value(s)
10th Mar 20237:15 amRNSEdison issues review on UIL (UTL)
9th Mar 202312:41 pmRNSNet Asset Value(s)
8th Mar 202311:59 amRNSNet Asset Value(s)
7th Mar 20232:56 pmRNSPublication of monthly factsheet
7th Mar 202311:08 amRNSNet Asset Value(s)
6th Mar 202312:03 pmRNSNet Asset Value(s)
3rd Mar 202312:18 pmRNSNet Asset Value(s)
2nd Mar 202311:08 amRNSNet Asset Value(s)
1st Mar 202311:54 amRNSNet Asset Value(s)
28th Feb 202311:56 amRNSNet Asset Value(s)
27th Feb 202311:26 amRNSNet Asset Value(s)
27th Feb 202311:17 amRNSHolding(s) in Company - UIL Limited
24th Feb 202312:03 pmRNSNet Asset Value(s)
23rd Feb 202311:36 amRNSNet Asset Value(s)
22nd Feb 202311:35 amRNSNet Asset Value(s)
21st Feb 202311:40 amRNSNet Asset Value(s)
21st Feb 20239:45 amRNSHalf-year Report
21st Feb 20239:45 amRNSHalf-year Report
21st Feb 20237:00 amRNSDividend Declaration - Q2 2022-23
20th Feb 202312:04 pmRNSNet Asset Value(s)
17th Feb 202312:47 pmRNSPublication of monthly factsheet
17th Feb 202312:13 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.